Premium
Pharmacists’ roles in nursing homes in Malaysia
Author(s) -
Mak Vivienne S. L.,
Lee Shaun W. H.,
March Geoff
Publication year - 2018
Publication title -
journal of pharmacy practice and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 22
eISSN - 2055-2335
pISSN - 1445-937X
DOI - 10.1002/jppr.1443
Subject(s) - medicine , pharmacist , nursing , family medicine , harm , exploratory research , nursing homes , health care , pharmacy , sociology , political science , anthropology , law , economics , economic growth
1 Cai Y, Lee W, Kwa A. Polymyxin B versus colistin: an update. Expert Rev Anti Infect Ther 2015; 13: 1481–97. 2 Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS, editors. The Sanford guide to antimicrobial therapy 2017. Sperryville, VA: Antimicrobial Therapy Incorporated; 2017. 3 Nation RL, Velkov T, Li J. Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis 2014; 59: 88–94. 4 Tran TV, Velkov T, Nation R, Forrest A, Tsuji BT, Bergen PJ, et al. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 2016; 48: 592–7. 5 Vardakas KZ, Falagas ME. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis. Int J Antimicrob Agents 2017; 49: 233–8.